Glenn S. Boehnlein
Net Worth

Last updated:

What is Glenn S. Boehnlein net worth?

The estimated net worth of Mr. Glenn S. Boehnlein is at least $34,354,878 as of 18 Nov 2024. He owns shares worth $1,112,109 as insider, has earned $21,722,769 from insider trading and has received compensation worth at least $11,520,000 in Stryker Corporation.

What is the salary of Glenn S. Boehnlein?

Mr. Glenn S. Boehnlein salary is $1,280,000 per year as Vice President & Chief Financial Officer in Stryker Corporation.

How old is Glenn S. Boehnlein?

Mr. Glenn S. Boehnlein is 63 years old, born in 1962.

What stocks does Glenn S. Boehnlein currently own?

As insider, Mr. Glenn S. Boehnlein owns shares in one company:

Company Title Shares Price per share Total value
Stryker Corporation (SYK) Vice President & Chief Financial Officer 2,852 $389.94 $1,112,109

What does Stryker Corporation do?

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Glenn S. Boehnlein insider trading

Stryker Corporation

Mr. Glenn S. Boehnlein has made 19 insider trades between 2016-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 49,150 units of SYK stock on 11 Jan 2024. As of 18 Nov 2024 he still owns at least 2,852 units of SYK stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 4,500 $122.51 $551,295
Option
Employee Stock Option granted 2/8/2017 (right to buy) 4,500 $122.51 $551,295
Sale
Common Stock 20,000 $333 $6,660,000
Option
Common Stock 25,000 $122.51 $3,062,750
Option
Employee Stock Option granted 2/8/2017 (right to buy) 25,000 $122.51 $3,062,750
Sale
Common Stock 10,000 $327.65 $3,276,520
Option
Dividend Equivalents 256 N/A N/A
Option
Common Stock 256 N/A N/A
Sale
Common Stock 9,600 $342.81 $3,290,957
Option
Employee Stock Option granted 02/11/2015 (right to buy) 10,855 $93.06 $1,010,166
Option
Common Stock 10,855 $93.06 $1,010,166
Option
Employee Stock Option granted 02/10/2016 (right to buy) 49,150 $96.64 $4,749,856
Option
Common Stock 49,150 $96.64 $4,749,856
Option
Common Stock 149 N/A N/A
Option
Dividend Equivalents 149 N/A N/A
Sale
Common Stock 7,708 $278.38 $2,145,722
Sale
Common Stock 7,709 $277.55 $2,139,664
Sale
Common Stock 125 $279.96 $34,995
Sale
Common Stock 8,883 $279.52 $2,482,967
Option
Common Stock 14,515 $64.01 $929,105
Option
Employee Stock Option granted 02/13/2013 (right to buy) 14,515 $64.01 $929,105
Option
Restricted Stock Units granted 05/04/2021 1,210 N/A N/A
Option
Common Stock 1,210 N/A N/A
Option
2019 Performance Stock Units 8,723 N/A N/A
Option
Common Stock 8,723 N/A N/A
Option
Restricted Stock Units granted 05/04/2021 170 N/A N/A
Option
Common Stock 170 N/A N/A
Sale
Common Stock 1,757 $259.68 $456,251
Sale
Common Stock 447 $258.98 $115,765
Sale
Common Stock 574 $260.78 $149,690
Sale
Common Stock 2,000 $246.01 $492,028
Sale
Common Stock 2,000 $239.11 $478,210
Sale
Common Stock 10,351 N/A N/A
Sale
Common Stock 2,700 N/A N/A
Sale
Common Stock 2,700 N/A N/A
Sale
Common Stock 2,700 N/A N/A
Option
Common Stock 35,529 N/A N/A
Option
Employee Stock Option granted 02/10/2009 (right to buy) 12,500 N/A N/A
Sale
Common Stock 750 N/A N/A
Sale
Common Stock 750 N/A N/A
Option
Restricted Stock Units granted 2/11/2015 904 N/A N/A
Option
Common Stock 904 N/A N/A
Option
Restricted Stock Units granted 02-11-2015 904 N/A N/A
Option
Restricted Stock Units granted 02-12-2014 996 N/A N/A
Option
Common Stock 1,900 N/A N/A
Sale
Common Stock 2,000 N/A N/A